Voltron Therapeutics
New York
About Voltron Therapeutics
Voltron Therapeutics is a Delaware corporation that specializes in cell-mediated responses. It develops precision-guided, self-assembling vaccines for cancer and infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Last round: Grant (Aug 2023)
- Website: voltrontx.com
- Phone: +1646-335-5923
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/voltron-therapeutics-104568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.